Article
Modified Sanliangsan improved Sjogren’s syndrome complicated with interstitial lung disease by suppressing serum MUC1 levels
2024-04-26
Abstract excerpt
<title>Abstract</title> <p>Objectives To clarify if the mechanism of Sanliangsan in improving Sjogren’s syndrome complicated with interstitial lung disease (SS-ILD) involves MUC1 suppression, which is involved in SS-ILD pathogenesis. Methods Fifty-six patients were randomly divided into two groups receiving Sanliangsan prescription therapy and conventional therapy. In-depth transcriptome profiles collected and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- afec1145-3970-5632-938b-c4e81a5ec8cb
- DOI
- 10.21203/rs.3.rs-4279300/v1
